Publication | Closed Access

Modulation of Sirt1/NF-κB interaction of evogliptin is attributed to inhibition of vascular inflammatory response leading to attenuation of atherosclerotic plaque formation

InflammationSirt1/nf-κb InteractionVascular DiseaseVascular Inflammatory ResponseCardiovascular DiseaseAtherosclerotic Plaque FormationImmunologyImmune RegulationPathologyChronic InflammationEndothelial DysfunctionVascular BiologyImmune FunctionMedicineInflammatory DiseaseAtherosclerosis